Hair Growth Treatment
Back in August 2017, UCLA researchers made headlines by discovering a new way to activate hair follicle stem cells. This was done through a metabolite called lactate. William Lowry and Heather Christofk of UCLA’s Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research were responsible for the lactate discovery. Lowry and Christofk…
Yesterday, Replicel released a May 2019 Update which mentioned a new study using its dermal injector device to treat hair loss. The end of the press release states: “Over the next 18 months you should expect to see: new clinical data from a study completed showing the value of the dermal injector in treating hair…
On April 24th-27th 2019 the 11th World Congress for Hair Research took place in Sitges, Barcelona. Usually, major announcements regarding the release of new treatments are not made at such conferences, however, worthwhile scientific information is typically shared. Importantly, companies who attend the WCHR are sometimes able to create business development opportunities. Below are some…
Puretech Health, the parent company of Follica, has recently issued a 2018 Annual Report to shareholders which contains news about its long-standing hair growth company. New Proprietary Compounds Among the important Follica news shared in the Puretech Annual Report is the mentioning of “next-generation proprietary compounds.” Yes, that compounds with an “s”, as in more…
Today, Cassiopea SpA has announced topline data from its fully completed phase 2 dose ranging trial for men with androgenic alopecia. The results of the trial were favorable. Phase 2 Trial for Clascoterone The trial which was completed by Cassiopea included 400 men and 4 different doses of clascoterone, also known as breezula, for the…
A new therapy targeting the PRL receptor to treat male and female pattern hair loss is being developed by a Chinese biopharmaceutical compay and Bayer AG. A press release was sent out April 7, 2019 by Hope Medicine Inc. detailing a newly signed licensing agreement with Bayer AG for the development of treatments for hair…
On February 4, 2019 Follicum announced via press release they have completed a preclinical trial using a new cream-like topical formulation of their peptide FOL-005. In the trial, Follicum measured the effects of their topical FOL-005 against industry standard hair-growth drug minoxidil. The trial was done on mice and took about four weeks to complete.…
RiverTown Therapeutics has engaged in an academic research collaboration to validate an effect of RT1640 that has already been observed in humans – gray hair reversal. A collaboration has begun between RiverTown Therapeutics and The University of Alabama at Birmingham with well-known hair pigment researcher Dr. Melissa Harris. You may remember Dr. Melissa Harris as…
Updated It’s been over a month since the long anticipated Trinov product was released in Italy. Across the internet you can find people sharing stories of their Trinov orders arriving. Now that the product is widely available and several readers of Follicle Thought have shared that they are now using the product, it’s time to…
Happy Holidays to all of the readers of Follicle Thought. I’m pleased to be bringing you all an exclusive interview with the UK-based startup HairClone, I hope you enjoy it with your celebrations this year. As many of you know, HairClone has recently launched a crowdfunding campaign in order to advance its R&D and setup…